Nifty
Sensex
:
:
23850.90
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 543444 | NSE: Not Listed

27.9
30-Oct-2024
  • Open
  • High
  • Low
  • Previous Close
  •  27.9
  •  27.9
  •  27.9
  •  26.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3000
  •  83700
  •  43.84
  •  23.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5.86
  • 162.75
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7.07
  • N/A
  • 1.41

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 56.82%
  • 12.00%
  • 28.18%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.00%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Net Sales
-
21.08
3.36
Net Sales Growth
-
527.38%
 
Cost Of Goods Sold
-
20.05
2.95
Gross Profit
-
1.03
0.41
GP Margin
-
4.89%
12.20%
Total Expenditure
-
20.96
3.33
Power & Fuel Cost
-
0.00
0.01
% Of Sales
-
0%
0.30%
Employee Cost
-
0.18
0.19
% Of Sales
-
0.85%
5.65%
Manufacturing Exp.
-
0.23
0.03
% Of Sales
-
1.09%
0.89%
General & Admin Exp.
-
0.16
0.10
% Of Sales
-
0.76%
2.98%
Selling & Distn. Exp.
-
0.21
0.02
% Of Sales
-
1.00%
0.60%
Miscellaneous Exp.
-
0.12
0.02
% Of Sales
-
0.57%
0.60%
EBITDA
-
0.12
0.03
EBITDA Margin
-
0.57%
0.89%
Other Income
-
0.01
0.02
Interest
-
0.04
0.01
Depreciation
-
0.04
0.03
PBT
-
0.05
0.01
Tax
-
0.01
0.00
Tax Rate
-
20.00%
0.00%
PAT
-
0.04
0.01
PAT before Minority Interest
-
0.04
0.01
Minority Interest
-
0.00
0.00
PAT Margin
-
0.19%
0.30%
PAT Growth
-
300.00%
 
EPS
-
0.19
0.05

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Shareholder's Funds
4.14
4.11
Share Capital
2.10
2.10
Total Reserves
2.04
2.01
Non-Current Liabilities
1.30
0.44
Secured Loans
0.00
0.00
Unsecured Loans
1.27
0.41
Long Term Provisions
0.00
0.00
Current Liabilities
9.90
0.45
Trade Payables
9.85
0.37
Other Current Liabilities
0.02
0.05
Short Term Borrowings
0.00
0.00
Short Term Provisions
0.03
0.02
Total Liabilities
15.34
5.00
Net Block
0.34
0.15
Gross Block
0.34
0.15
Accumulated Depreciation
0.00
0.00
Non Current Assets
0.42
0.22
Capital Work in Progress
0.00
0.00
Non Current Investment
0.00
0.00
Long Term Loans & Adv.
0.04
0.04
Other Non Current Assets
0.04
0.04
Current Assets
14.93
4.78
Current Investments
0.00
0.00
Inventories
1.33
1.19
Sundry Debtors
12.61
2.53
Cash & Bank
0.06
0.24
Other Current Assets
0.92
0.00
Short Term Loans & Adv.
0.92
0.82
Net Current Assets
5.03
4.33
Total Assets
15.35
5.00

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Cash From Operating Activity
-0.77
-0.68
PBT
0.05
0.01
Adjustment
0.08
0.04
Changes in Working Capital
-0.89
-0.71
Cash after chg. in Working capital
-0.76
-0.67
Interest Paid
0.00
0.00
Tax Paid
-0.01
-0.01
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
-0.28
-0.01
Net Fixed Assets
-0.09
Net Investments
-0.05
Others
-0.14
Cash from Financing Activity
0.86
0.34
Net Cash Inflow / Outflow
-0.18
-0.35
Opening Cash & Equivalents
0.24
0.59
Closing Cash & Equivalent
0.06
0.24

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Book Value (Rs.)
19.73
19.59
ROA
0.35%
0.22%
ROE
0.87%
0.26%
ROCE
1.76%
0.56%
Fixed Asset Turnover
85.79
22.58
Receivable days
131.05
274.52
Inventory Days
21.83
128.97
Payable days
93.03
46.16
Cash Conversion Cycle
59.85
357.33
Total Debt/Equity
0.31
0.10
Interest Cover
2.32
1.91

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.